Ovid Therapeutics Inc. Diluted Shares Outstanding (Weighted Average)
Ovid Therapeutics Inc. (OVID) reported Diluted Shares Outstanding (Weighted Average) of 70.98 million shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2024-11-12
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 70.98M shares, a 0.51% increase year-over-year.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-06-30 was 71.20M shares, a 0.95% increase year-over-year.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-03-31 was 70.72M shares, a 0.32% increase year-over-year.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-12-31 was 70.69M shares, a 0.31% increase year-over-year.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 70.58M shares, a 0.22% increase from fiscal 2022.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 70.42M shares, a 3.46% increase from fiscal 2021.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 68.07M shares, a 16.45% increase from fiscal 2020.
- Ovid Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2020 was 58.45M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2024-09-30 | 70.98M shares 10-Q · filed 2024-11-12 | 71.09M shares derived: average of 2 quarters · filed 2024-11-12 | 70.87M shares 10-Q · filed 2024-11-12 | 70.90M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 71.20M shares 10-Q · filed 2024-08-13 | 70.82M shares 10-Q · filed 2024-08-13 | 70.87M shares derived: average of 3 quarters · filed 2024-08-13 | 70.81M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | 70.72M shares 10-Q · filed 2024-05-14 | 70.70M shares derived: average of 2 quarters · filed 2024-05-14 | 70.67M shares derived: average of 3 quarters · filed 2024-11-12 | 70.64M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | 70.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 70.65M shares derived: average of 2 quarters · filed 2024-11-12 | 70.61M shares derived: average of 3 quarters · filed 2024-11-12 | 70.58M shares 10-K · filed 2024-03-08 |
| 2023-09-30 | 70.62M shares 10-Q · filed 2024-11-12 | 70.58M shares derived: average of 2 quarters · filed 2024-11-12 | 70.54M shares 10-Q · filed 2024-11-12 | 70.53M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 70.53M shares 10-Q · filed 2024-08-13 | 70.51M shares 10-Q · filed 2024-08-13 | 70.50M shares derived: average of 3 quarters · filed 2024-08-13 | 70.48M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 70.49M shares 10-Q · filed 2024-05-14 | 70.48M shares derived: average of 2 quarters · filed 2024-05-14 | 70.46M shares derived: average of 3 quarters · filed 2024-05-14 | 70.45M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 70.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 70.45M shares derived: average of 2 quarters · filed 2024-03-08 | 70.43M shares derived: average of 3 quarters · filed 2024-03-08 | 70.42M shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 70.43M shares 10-Q · filed 2023-11-03 | 70.41M shares derived: average of 2 quarters · filed 2023-11-03 | 70.41M shares 10-Q · filed 2023-11-03 | 69.97M shares derived: average of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | 70.39M shares 10-Q · filed 2023-08-04 | 70.39M shares 10-Q · filed 2023-08-04 | 69.82M shares derived: average of 3 quarters · filed 2023-08-04 | 69.35M shares derived: average of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | 70.35M shares 10-Q · filed 2023-05-05 | 69.54M shares derived: average of 2 quarters · filed 2023-05-05 | 69.00M shares derived: average of 3 quarters · filed 2023-05-05 | 68.71M shares derived: average of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | 68.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 68.33M shares derived: average of 2 quarters · filed 2023-03-13 | 68.16M shares derived: average of 3 quarters · filed 2023-03-13 | 68.07M shares 10-K · filed 2023-03-13 |
| 2021-09-30 | 67.93M shares 10-Q · filed 2022-11-08 | 67.87M shares derived: average of 2 quarters · filed 2022-11-08 | 67.85M shares 10-Q · filed 2022-11-08 | 66.59M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 67.82M shares 10-Q · filed 2022-08-09 | 67.57M shares 10-Q · filed 2022-08-09 | 66.15M shares derived: average of 3 quarters · filed 2022-08-09 | 64.46M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 66.58M shares 10-Q · filed 2022-05-10 | 65.31M shares derived: average of 2 quarters · filed 2022-05-10 | 63.34M shares derived: average of 3 quarters · filed 2022-05-10 | 61.41M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 64.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 61.73M shares derived: average of 2 quarters · filed 2022-03-15 | 59.69M shares derived: average of 3 quarters · filed 2022-03-15 | 58.45M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 59.41M shares 10-Q · filed 2021-11-10 | 57.51M shares derived: average of 2 quarters · filed 2021-11-10 | 56.59M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 55.61M shares 10-Q · filed 2021-08-16 | 55.16M shares 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | 54.72M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |